Navigation Links
Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert
Date:2/9/2009

M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company will be holding two free webinars to discuss how state-of-the-art image management can enhance DXA (Dual Energy X-Ray Absorptiometry) quality assurance services for bone mineral density trials and issues to consider in trials using body composition measurements with DXA.

(PRWEB) January 27, 2009 -- M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company will be holding two free webinars to discuss how state-of-the-art image management can enhance DXA (Dual Energy X-Ray Absorptiometry) quality assurance services for bone mineral density trials and issues to consider in trials using body composition measurements with DXA.

On February 3, 2009 (1:00pm EST), an expert from M2S' DXA Division will present the benefits of electronic image transfer, real-time web-based tracking and processing of DXA bone mineral density images and discuss the potential time and cost savings. The second webinar, to be held February 10 (1:00pm EST), will provide useful information on potential challenges and issues in clinical trials using body composition measurements such as patient positioning, use of phantoms, analysis and outcomes decisions.

DXA (Dual- Energy X-Ray Absorptiometry) is a low-dose (1/10th of traditional x-ray) imaging modality that measures bone mineral density and body mass composition. It is increasingly utilized in clinical trials to assess the safety and effectiveness of drugs under development for osteoporosis, HIV, obesity, oncology, as well as hormonal therapies and pediatric indications.

"These webinars will provide insight and advice on how electronic image transfer can improve the speed and reduce the costs of collecting DXA images in clinical trials and provide useful information for planning trials using body composition," said Reta Rupich, Vice President, M2S DXA division.

To sign up for one or both free webinars, go to our DXA Webinar Sign up Page

About M2S, Inc.:
M2S provides image and data management services for clinical trials sponsors in the biopharmaceutical and medical device industries, patient registry databases and is a recognized leader in 3-D endovascular treatment planning. On December 31, 2008 M2S acquired DXA Resource Group (DRG), a clinical trials service company focused on providing customer-centric, cost-effective quality assurance as well as data and project management for clinical trials involving DXA measurements. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in various therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com or www.dxaresourcegroup.com.

###

Read the full story at http://www.prweb.com/releases/electronic/imaging/prweb1917154.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert
2. AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to Consumers
3. deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
4. South Africas Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
5. Sea urchin yields a key secret of biomineralization
6. New insight to demineralization
7. Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear
8. New property found in ancient mineral lodestone
9. 220 Companies Place Switzerland First in Biotech Density Per Capita
10. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
11. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert 
(Date:1/24/2017)... ... January 24, 2017 , ... Men who have a ... had a positive association with increased prostate growth or benign prostatic hyperplasia, according ... Journal involved 571 Korean men who underwent urological examinations, including serum prostate ...
(Date:1/24/2017)... USA & Geneva, Switerland (PRWEB) , ... January ... ... to announce the first commercially available malaria Plasmodium falciparum culture panels with standard ... falciparum culture panels, which are available in a range of concentrations from six ...
(Date:1/24/2017)... LAVAL, QC , Jan. 24, 2017 /PRNewswire/ - ProMetic ... the "Corporation") announced today that its orally active lead ... Medicine ("PIM") designation by the UK Medicines and Healthcare ... Syndrome ("AS"). A PIM designation is ... promising candidate for the Early Access to Medicines Scheme ...
(Date:1/24/2017)... DC (PRWEB) , ... January 23, 2017 , ... ... and food security, is the first-ever recipient of the National Academy of Sciences ... to global food security and nutrition. , The annual National Academy of Sciences ...
Breaking Biology Technology:
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
(Date:12/15/2016)... ... has announced the addition of the "Global Military Biometrics Market 2016-2020" ... global military biometrics market to grow at a CAGR of 7.5% during ... on an in-depth market analysis with inputs from industry experts. The report ... The report also includes a discussion of the key vendors operating in ...
(Date:12/15/2016)... 14, 2016 "Increase in mobile transactions is ... mobile biometrics market is expected to grow from USD ... 2022, at a CAGR of 29.3% between 2016 and ... the growing demand for smart devices, government initiatives, and ... "Software component is expected to grow at a high ...
Breaking Biology News(10 mins):